Canada
· Delayed Price · Currency is CAD NuGen Medical Devices Statistics
Total Valuation
NuGen Medical Devices has a market cap or net worth of CAD 17.42 million. The enterprise value is 27.33 million.
| Market Cap | 17.42M |
| Enterprise Value | 27.33M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NuGen Medical Devices has 217.73 million shares outstanding. The number of shares has increased by 50.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 217.73M |
| Shares Change (YoY) | +50.14% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 2.89% |
| Owned by Institutions (%) | n/a |
| Float | 210.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.96 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.29 |
| EV / Sales | 35.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.62 |
Financial Position
The company has a current ratio of 3.12
| Current Ratio | 3.12 |
| Quick Ratio | 2.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.07 |
| Interest Coverage | -5.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.95% |
| Return on Capital (ROIC) | -40.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.27% in the last 52 weeks. The beta is 2.55, so NuGen Medical Devices's price volatility has been higher than the market average.
| Beta (5Y) | 2.55 |
| 52-Week Price Change | -27.27% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 40.20 |
| Average Volume (20 Days) | 243,717 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NuGen Medical Devices had revenue of CAD 762,792 and -8.31 million in losses. Loss per share was -0.04.
| Revenue | 762,792 |
| Gross Profit | 358,626 |
| Operating Income | -6.49M |
| Pretax Income | -8.27M |
| Net Income | -8.31M |
| EBITDA | -5.95M |
| EBIT | -6.49M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 9.34 million in cash and 19.26 million in debt, giving a net cash position of -9.92 million or -0.05 per share.
| Cash & Cash Equivalents | 9.34M |
| Total Debt | 19.26M |
| Net Cash | -9.92M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | -6.61M |
| Book Value Per Share | -0.03 |
| Working Capital | 6.84M |
Cash Flow
In the last 12 months, operating cash flow was -3.17 million and capital expenditures -3,022, giving a free cash flow of -3.17 million.
| Operating Cash Flow | -3.17M |
| Capital Expenditures | -3,022 |
| Free Cash Flow | -3.17M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 47.01% |
| Operating Margin | -850.30% |
| Pretax Margin | -1,084.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NuGen Medical Devices does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.14% |
| Shareholder Yield | -50.14% |
| Earnings Yield | -49.62% |
| FCF Yield | -18.21% |
Stock Splits
The last stock split was on November 8, 2021. It was a reverse split with a ratio of 0.5.
| Last Split Date | Nov 8, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
NuGen Medical Devices has an Altman Z-Score of -3.35. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.35 |
| Piotroski F-Score | n/a |